Table 1 Characteristics of studies included in the meta-analysis
Author, year | Year of study | Country | Disease stage | Operation type | Chemotherapy type | No. of VTEs | No. of participants | VTE diagnostic criterion | Study design |
|---|---|---|---|---|---|---|---|---|---|
Fotopoulou et al., 2008 [27] | 1995–2002 | Germany | Advanced ovarian cancer | Debulking surgery | Adjuvant chemotherapy | 76 | 2743 | National Cancer Institute Common Toxicity Criteria | Case-control |
Fotopoulou et al., 2009 [14] | 1999–2005 | Germany | Recurrent ovarian cancer | Radical surgery | Adjuvant chemotherapy | 37 | 525 | National Cancer Institute Common Toxicity Criteria | Case-control |
Mereu et al., 2009 [28] | 1990–2004 | Italy | Ovarian cancer | Radical surgery | Adjuvant chemotherapy | 16 | 203 | Self-definition | Cross-sectional study |
Guardiola et al., 2010 [29] | 2004–2007 | France | Recurrent ovarian cancer | Debulking surgery | Neoadjuvant chemotherapy | 3 | 18 | National Cancer Institute Common Toxicity Criteria | Cross-sectional study |
Saadeh et al., 2013 [30] | 2006–2010 | Ireland | Ovarian cancer | Radical surgery | Neoadjuvant chemotherapy or adjuvant chemotherapy | 31 | 227 | Self-definition | Case-control |
Pant et al., 2014 [31] | 2008–2011 | The USA | Advanced ovarian cancer | Radical surgery | Adjuvant chemotherapy | 16 | 128 | Self-definition | Case-control |
Chavan et al., 2017 [15] | 2012–2015 | China | Ovarian cancer | Radical surgery | Neoadjuvant chemotherapy or adjuvant chemotherapy | 20 | 147 | Self-definition | Retrospective cohort |
Greco et al., 2017 [32] | 2009–2014 | The USA | Advanced ovarian cancer | Debulking surgery | Neoadjuvant chemotherapy | 12 | 111 | Self-definition | Retrospective cohort |
Kuk et al., 2017 [33] | NA | Poland | Advanced ovarian cancer | Debulking surgery | Adjuvant chemotherapy | 5 | 57 | Self-definition | Case-control |
Zhang et al., 2018 [16] | 2014–2017 | China | Ovarian cancer | Debulking surgery | Neoadjuvant chemotherapy | 35 | 370 | Self-definition | Case-control |
Salinaro et al., 2020 [17] | 2000–2013 | The USA | Ovarian cancer | Debulking surgery | Neoadjuvant chemotherapy | 16 | 230 | Self-definition | Retrospective cohort |